Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3K/AKT pathway in human pancreatic cancer cells.

Xu Li,Feng Zhu,Jianxin Jiang,Chengyi Sun,Xin Wang,Ming Shen,Rui Tian,Chengjian Shi,Meng Xu,Feng Peng,Xingjun Guo,Min Wang,Renyi Qin
DOI: https://doi.org/10.1016/j.canlet.2014.11.026
IF: 9.756
2015-01-01
Cancer Letters
Abstract:•The combination of oxaliplatin and withaferin A has a synergistic antitumor activity in PC cells in vitro and in vivo.•This synergistic effect occurred primarily through increased generation of intracellular ROS.•The generation of ROS was involved in the induction of mitochondrial dysfunction and inhibition of PI3K/AKT signaling.
What problem does this paper attempt to address?